Variation of Stroke-associated Pneumonia in Stroke Units Across England and Wales: A Registry-based Cohort Study
Overview
Affiliations
Background: Pneumonia is common in stroke patients and is associated with worse clinical outcomes. Prevalence of stroke-associated pneumonia varies between studies, and reasons for this variation remain unclear. We aimed to describe the variation of observed stroke-associated pneumonia in England and Wales and explore the influence of patient baseline characteristics on this variation.
Methods: Patient data were obtained from the Sentinel Stroke National Audit Programme for all confirmed strokes between 1 April 2013 and 31 December 2018. Stroke-associated pneumonia was defined by new antibiotic initiation for pneumonia within the first seven days of admission. The probability of stroke-associated pneumonia occurrence within stroke units was estimated and compared using a multilevel mixed model with and without adjustment for patient-level characteristics at admission.
Results: Of the 413,133 patients included, median National Institutes of Health Stroke Scale was 4 (IQR: 2-10) and 42.3% were aged over 80 years. Stroke-associated pneumonia was identified in 8.5% of patients. The median within stroke unit stroke-associated pneumonia prevalence was 8.5% (IQR: 6.1-11.5%) with a maximum of 21.4%. The mean and variance of the predicted stroke-associated pneumonia probability across stroke units decreased from 0.08 (0.68) to 0.05 (0.63) when adjusting for patient admission characteristics. This difference in the variance suggests that clinical characteristics account for 5% of the observed variation in stroke-associated pneumonia between units.
Conclusions: Patient-level clinical characteristics contributed minimally to the observed variation of stroke-associated pneumonia between stroke units. Additional explanations for the observed variation in stroke-associated pneumonia need to be explored which could reduce variation in antibiotic use for stroke patients.
A Novel Nomogram for Predicting the Risk of Pneumonia After Intracerebral Hemorrhage.
Sun Y, Zhang L, Huang B, He Q, Hu B J Inflamm Res. 2025; 18:1333-1351.
PMID: 39902381 PMC: 11789516. DOI: 10.2147/JIR.S490064.
Bacterial stroke-associated pneumonia: microbiological analysis and mortality outcome.
Aboulfotooh A, Abdel Aziz H, Zein M, Sayed M, Ibrahim A, Abdelaty L BMC Neurol. 2024; 24(1):265.
PMID: 39080572 PMC: 11290281. DOI: 10.1186/s12883-024-03755-4.
Krongsut S, Soontornpun A, Anusasnee N Front Neurol. 2024; 15:1364125.
PMID: 38711555 PMC: 11071176. DOI: 10.3389/fneur.2024.1364125.
Wang J, Yang C, Zhang R, Hu W, Yang P, Jiang Y Front Med (Lausanne). 2024; 11:1370986.
PMID: 38504915 PMC: 10948544. DOI: 10.3389/fmed.2024.1370986.
Stroke-associated pneumonia according to mCDC criteria: impact on prognosis and antibiotic therapy.
Rabaneda-Lombarte N, Faura J, Ezcurra-Diaz G, Olive-Gadea M, Alvarez-Larruy M, Vidal-de Francisco D Front Neurol. 2024; 15:1358628.
PMID: 38497035 PMC: 10941756. DOI: 10.3389/fneur.2024.1358628.